Fetal and Neonatal Monitoring Devices Market is projected to grow to US$ 13.6 billion by 2031 | GE HealthCare, Medtronic, Drägerwerk AG, Natus Medical Incorporated, Fisher & Paykel Healthcare, Vyaire Medical

The global fetal and neonatal monitoring devices market was valued at US$ 8.18 billion in 2023 and is projected to grow to approximately US$ 13.6 billion by 2031, registering a compound annual growth rate (CAGR) of 6.6% during the forecast period from 2024 to 2031.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/fetal-neonatal-monitoring-market?sg

Key Market Drivers:

• Rising Preterm Birth Rates:
The increasing number of premature births globally has driven demand for continuous monitoring solutions to ensure timely interventions and reduce neonatal complications.

• Advancements in Monitoring Technologies:
Innovations such as wireless, portable, and AI-integrated devices have significantly improved the accuracy, convenience, and efficiency of fetal and neonatal monitoring.

• Growing Awareness and Government Initiatives:
Educational campaigns and national programs aimed at improving maternal and infant health outcomes have boosted the adoption of monitoring devices in both developed and developing regions.

• Expanding NICU Facilities:
Hospitals are increasingly investing in state-of-the-art neonatal intensive care units equipped with advanced monitoring systems, especially in urban centers and tertiary care hospitals.

• Increasing Incidence of High-Risk Pregnancies:
Factors such as maternal age, gestational diabetes, and hypertension have led to a rise in high-risk pregnancies, necessitating comprehensive monitoring throughout gestation and after delivery.

Market Segments:
• By Product Type (Fetal Monitoring Devices, Neonatal Monitoring Devices)
• By Portability (Portable Monitoring Devices, Non-Portable Monitoring Devices)
• By End-User (Hospitals, Neonatal Clinics, Obstetrics and Gynecology Clinics, Others)
• By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/fetal-neonatal-monitoring-market?sg

Market Geographical Share:

• The North American region dominates the fetal and neonatal monitoring devices market, primarily due to the high prevalence of preterm births, advanced healthcare infrastructure, and increased awareness of perinatal care. The United States accounts for the largest share, driven by significant investments in neonatal intensive care units (NICUs) and the widespread adoption of advanced monitoring technologies.

• Europe follows closely, with countries such as Germany, France, and the United Kingdom showing robust adoption of fetal and neonatal monitoring systems. Government-supported maternal health programs and improved access to healthcare services contribute to regional growth.

• Asia-Pacific is emerging as the fastest-growing market, spurred by rising birth rates, expanding healthcare access in rural areas, and growing investments in hospital infrastructure. Countries like China, India, and Japan are focusing on reducing infant mortality rates through enhanced prenatal and neonatal monitoring systems.

Market Key Players:
Key players are Cardinal Health, Koninklijke Philips N.V., GE HealthCare., Medtronic, Drägerwerk AG & Co. KGaA, Natus Medical Incorporated, Fisher & Paykel Healthcare Limited., Utah Medical Products, Inc., Vyaire Medical, Inc. and Masimo.

Request for FREE Trial Access: https://www.datamintelligence.com/reports-subscription?sg

Key M&A & Strategic Moves:

• Drägerwerk AG acquired Air Shields ( Hill Rom's infant care division) in June 2024, significantly boosting its neonatal intensive care portfolio in the U.S. neonatal segment.

• ArchiMed Group completed the acquisition of Natus Medical in mid 2022 (~$1.2 billion), inheriting Natus's brain monitoring and neuro diagnostics systems widely used in neonatal care.

• Samsung's acquisition of Sonio added AI‐powered fetal ultrasound analytics into its imaging business, reinforcing the trend of big players buying niche diagnostic software firms.

Recent & 2025 Product Launches:

• GE Healthcare's Novii+ Wireless Patch Solution earned FDA 510(k) clearance in early 2024 to monitor fetal heart rate, maternal heart rate, and uterine activity non‐invasively starting at 34 weeks. The belt‐free wireless patch offers greater mobility during labor.

• Clarius OB AI handheld ultrasound device received FDA clearance in June 2024. It automates fetal biometry such as fetal age and weight via AI and supports point‐of‐care use outside conventional ultrasound rooms.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.